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Objectives The purpose of this study was to determine the pattern of cardiac stress testing after coronary revascularization
in community practice.
Background The American College of Cardiology Foundation appropriate use criteria provide guidance for the use of cardiac
stress imaging after coronary revascularization. However, little is known regarding the use of routine cardiac
stress testing in coronary artery bypass grafting or percutaneous coronary intervention patients as well as their
downstream use of invasive procedures after noninvasive testing in community practice.
Methods Use and timing of stress testing more than 90 days after revascularization in patients 18 to 64 years of age
were determined from a national health insurance claims database from July 1, 2004, through June 30, 2007.
Subsequent rates of angiography and repeat revascularization after stress testing also were examined.
Results Of 28,177 patients undergoing revascularization (21,046 percutaneous coronary intervention procedures and
7,131 coronary artery bypass grafting procedures), 59% had at least 1 cardiac stress test within 24 months.
Sixty-one percent of patients with percutaneous coronary intervention and 51% of patients with coronary artery
bypass grafting had undergone testing by 24 months. Nuclear imaging was the predominant testing method.
The incidence of testing was found to increase at both 6 months and 12 months after revascularization, suggest-
ing an association with elective follow-up office visits. Furthermore, testing varied according to geographic loca-
tion. Of those tested, only 11% underwent subsequent cardiac catheterization and only 5% underwent repeat
revascularization.
Conclusions Although there is limited consensus as to the appropriate role of elective stress testing after coronary revascular-
ization, more than one half of all patients in community practice had at least 1 stress test within 24 months of
revascularization. Yield on such testing was low: only 5% of patients tested ultimately required repeat revascu-
larization. These findings support the need to define better the role of stress testing after recent
revascularization. (J Am Coll Cardiol 2010;56:1328–34) © 2010 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.03.093p
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roninvasive stress testing, with or without imaging meth-
ds such as echocardiography, nuclear imaging, and mag-
etic resonance, improves assessment of cardiac anatomic
nd pathologic features. Although these testing methods
an assist in patient management, there has been rapid
xpansion in their use over time, and noninvasive imaging
as been among the fastest growing components of any
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mployees of UnitedHealthCare. Dr. Cowper has received research grant support
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Manuscript received December 20, 2009; accepted March 10, 2010.hysician service in recent years (1,2). This growth has come
ithout sufficient evidence to determine the impact of
esting on clinical outcomes (3,4).
To help guide diagnostic imaging use, the American
ollege of Cardiology Foundation (ACCF) has recently
eveloped appropriate use criteria (AUC) (5–7). The
CCF AUC aim to assist clinical decision-making by
utlining available evidence coupled with expert consensus
n the optimal use of imaging in various clinical situations.
See page 1335
ne area with limited data in the ACCF AUC was the
outine use of stress testing with imaging (nuclear, echocar-
iography) after revascularization. However, expert consen-
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October 12, 2010:1328–34 Cardiac Stress Testing After Revascularizationus concluded that stress testing generally was inappropriate
ithin 2 years for percutaneous coronary intervention
PCI) and within 5 years for coronary artery bypass
rafting (CABG), unless prompted by symptoms or other
hange in clinical status (7).
Having access to an administrative database from a
arge national health insurer, we sought to assess clinical
ractice patterns and frequency of stress testing use in
atients after coronary revascularization. We also as-
essed patient and geographic variation in these testing
atterns. Finally, we examined downstream angiography
nd repeat revascularization rates that resulted from
nitial stress testing.
ethods
ata source. Data were obtained from UnitedHealth-
are’s administrative billing records for more than 17.7
illion members enrolled in employer-sponsored plans
rom July 1, 2004, through June 30, 2007. All claims
inpatient and outpatient hospital encounters, physician
laims) and enrollment information were provided for
nitedHealthCare patients who underwent coronary revas-
ularization with either CABG or PCI during this period.
ospital claims included International Classification of
iseases-9th Revision-Clinical Modification (ICD-9) diag-
osis and procedure codes, Current Procedure Terminology
CPT) procedure codes, dates of service, discharge disposi-
ion, and zip code of provider. Physician claims included
CD-9 diagnosis codes, CPT procedure codes, and dates of
ervice. Death dates from the Social Security Death Master
ile also were provided for the sample. To ensure continu-
us longitudinal follow-up, for the small number (3%) of
atients with discontinuous enrollment periods, only the
rst enrollment period was considered.
Revascularization procedures were identified using CPT
nd ICD-9 codes (PCI, 92980 through 92982, 92973,
2984, 92995 through 92996, G0290 through G0291,
6.0x, 00.66; CABG, 33510 through 33529, 33533 through
3536, 36.1x, 36.2, 36.31, 36.32). Patients with revascular-
zation claims that appeared in either the hospital or
hysician claims but not in both sources were excluded from
he analysis because of incomplete data capture.
tress testing. Cardiac stress and imaging tests were iden-
ified by CPT codes (electrocardiographic [ECG] stress,
3015 through 93018; nuclear, 78460 through 78461,
8464 through 78466, 78468 through 78469, 78472
hrough 78473, 78481, 78483, 78491 through 78492,
8494; stress echocardiography, 93350). ECG stress and
uclear imaging procedures performed within 72 h of each
ther were considered a single stress nuclear event. ECG
tress and echocardiographic testing performed on the same
ay were considered a single stress echocardiography event.
ardiac stress tests occurring within the first 90 days after
evascularization were assumed to be performed for the
urposes of cardiac rehabilitation, staging of procedures, or cunctional capacity assessments
nd were not counted as a post-
evascularization stress study.
he indications for stress testing
ere identified using ICD-9
odes recorded at the time of the
tress test.
The first identified PCI or
ABG procedure for each pa-
ient was considered the index
evascularization. Multiple revas-
ularization procedures within a
ingle encounter were considered
s a single revascularization event
or the current analysis. For each
atient, we extracted physician
laims for all stress tests, coro-
ary angiographies, and coronary
evascularizations as well as inpatient and outpatient hospi-
al revascularization and angiography claims occurring after
he index revascularization procedure. Patients were in-
luded in the primary analysis if they survived 90 days after
evascularization without a competing event (death, angiog-
aphy, or repeat revascularization) or loss of coverage.
tatistical analysis. Characteristics of patients undergoing
evascularization with PCI or CABG were examined. Time
o the first stress test occurring 90 days after the index
evascularization episode was examined using cumulative
ncidence functions that accounted for administrative cen-
oring and treated coronary angiography, repeat revascular-
zation, and death as competing risks. In addition to
xamining overall stress testing incidence, stress echocardi-
graphy and stress nuclear and ECG stress testing were
nalyzed separately. These analyses were repeated after
tratifying by sex, age, comorbidities identified by ICD-9
odes at the time of index revascularization, and core-based
tatistical area. The core-based statistical area is a standard
egional classification based around an urban center with a
opulation of at least 10,000 (8). The univariate association
etween cumulative incidence and variables of interest was
ssessed using the Gray test (9).
For patients undergoing stress testing, we analyzed the
ates of coronary angiography within 30 days of stress
esting as well as the rate of repeat revascularization within
0 days of coronary angiography. The 30-day follow-up
indows were chosen to capture sequential procedures most
ikely to result from testing. To determine the effect on the
nalysis of excluding stress tests within 90 days of the index
evascularization, we removed the 90-day allowance in a
ensitivity analysis and examined all stress tests after the
evascularization date.
The Duke University Institutional Review Board re-
iewed and approved the study design. All statistical anal-
ses were performed using SAS software version 9.2 (SAS
nstitute, Cary, North Carolina) and R Project for Statisti-
Abbreviations
and Acronyms
ACCF  American College
of Cardiology Foundation
AUC  appropriate use
criteria
CABG  coronary artery
bypass grafting
CPT  Current Procedure
Terminology
ECG  electrocardiographic
ICD-9  International
Classification of Diseases-
9th Revision-Clinical
Modification
PCI  percutaneous
coronary interventional Computing software version 2.11.0 (10).
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Cardiac Stress Testing After Revascularization October 12, 2010:1328–34esults
atient cohort. We identified 36,598 members at least 18
ears and younger than 65 years of age with a revascular-
zation with CABG or PCI during the study period. Of
hese patients, 28,177 patients (21,046 with PCI and 7,131
ith CABG) had a minimum of 90 days of follow-up
ithout a competing risk within 90 days of their first
evascularization. The mean follow-up available for patients
ndergoing revascularization was 404  254 days. Table 1
rovides characteristics of patients at the time of the index
oronary revascularization based on ICD-9 classification of
omorbid diagnoses. Patients undergoing PCI were more
ikely to be female, have a diagnosis of hyperlipidemia, and
moke tobacco, whereas patients undergoing CABG were
ore likely to have a diagnosis of congestive heart failure
nd chronic obstructive pulmonary disease.
Table 2 shows ICD-9 diagnosis codes for initial stress
esting after revascularization stratified by revascularization
rocedure. There was no clinically significant difference in
he indications for testing between the 2 groups, but coding
or clinical symptoms accounted for approximately one third
f all testing.
attern of stress testing. Figure 1 depicts the cumulative
ncidence of initial stress testing between 90 days and 24
onths after revascularization. The 12-month cumulative
ncidence of testing was 36% overall, with a rate of 39% and
8% in PCI and CABG patients, respectively. Fifty-eight
ercent of patients undergoing revascularization underwent
t least 1 cardiac stress test within 24 months of coronary
atient Characteristics at theime of oronary RevascularizationTable 1 P ient Characteristics at theTime of Coronary Revascularization
All
(n  28,177)
PCI
(n  21,046)
CABG
(n  7,131) p Value
Age (yrs) 55 6 55 6 56 6 0.001
Female 21 22 18 0.001
Acute myocardial
infarction
29 32 20 0.001
Region 0.001
Northeast 10 10 8
South 49 48 51
Midwest 29 29 28
West 13 13 12
Diabetes mellitus 19 19 20 0.13
Congestive heart failure 6 4 11 0.001
Hyperlipidemia 44 48 31 0.001
Previous myocardial
infarction
6 6 5 0.05
History of stroke 1 1 2 0.001
Peripheral vascular
disease
2 1 2 0.001
Chronic obstructive
pulmonary disease
8 6 14 0.001
Renal failure 0.9 0.8 1.2 0.001
Tobacco use 14 15 9 0.001
ll values are expressed as percentages unless otherwise specified.
CABG  coronary artery bypass grafting; PCI  percutaneous coronary intervention.evascularization, with 61% and 51% of PCI and CABGatients tested, respectively. When tests within the first 90
ays after revascularization were included in a sensitivity
nalysis, the 24-month cumulative incidence of stress test-
ng after revascularization was 61%, with 62% and 58% of
CI and CABG patients being tested, respectively.
The distribution of testing method used and multiple
tress testing rates after revascularization are shown in Table 3.
uclear imaging was the most frequently used testing
ethod after revascularization, particularly among patients
ith PCI. Eleven percent of all patients with revasculariza-
ion had a second stress test performed within 24 months
ithout an intervening angiography or repeat revasculariza-
ion procedure. PCI patients had a shorter median time to
rst stress test than CABG patients (380 days vs. 610 days).
ithin 24 months of revascularization, 5% of patients
nderwent angiography without prior stress testing (6% and
nternational Classification of Diseases-9thevision-Clinical Modification Indications for Initialtr s Testing After Rev scular zation
Table 2
International Classific tion of Diseases-9th
Revision-Clinical Modification Indications for Initial
Stress Testing After Revascularization
All
(n  11,788)
PCI
(n  9,315)
CABG
(n  2,473)
Ischemic heart disease (414.0X) 73 73 71
Chest pain
(786.50, 786.51,786.59)
24 24 23
Angina (413.X) 6 6 5
Chest pain or angina
(786.50, 786.51,786.59, 413.X)
29 30 28
Shortness of breath (786.05) 4 4 5
Acute myocardial infarction
(410.XX)
2 2 1
Acute coronary syndrome (411.1) 1 1 1
Other 10 9 12
alues are expressed as a percentage of total number of stress tests after revascularization.
ercentages do not sum to 100% because of multiple indications per stress test.
Abbreviations as in Table 1.
Figure 1 Cumulative Incidence of Cardiac Stress Testing
After Coronary Revascularization
Graph showing the cumulative incidence of stress testing between 90 days
and 24 months after revascularization overall and by revascularization type.
CABG  coronary artery bypass grafting; PCI  percutaneous coronary
intervention.
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October 12, 2010:1328–34 Cardiac Stress Testing After Revascularization% for PCI and CABG, respectively) and 4% of patients
nderwent repeat revascularization without prior testing.
he incidence of death (without intervening stress, angiog-
aphy, or revascularization) at 24 months was 0.7%.
Figure 2 shows the additional proportion of patients
ndergoing stress testing in successive 30-day intervals after
evascularization, stratified by revascularization type. Two
eriods were observed to have increased testing after revas-
ularization, 180 to 210 days and 360 to 390 days, with the
reatest increase in the proportion of patients having their
rst stress test occurring at 180 to 210 days after PCI.
actors affecting patterns of stress testing. Table 4 shows
tress testing incidence in patients stratified by sex, age, and
omorbid conditions at the time of index revascularization.
esting declined slightly with age. However, patients with-
ut diabetes and congestive heart failure had clinically
ignificant higher rates of testing those with disease. Testing
atterns varied moderately among core-based statistical
reas, with the proportion of patients undergoing stress
esting without subsequent angiography or repeat revascu-
arization ranging from 51% to 71% at 24 months (p 
.001) (Fig. 3).
tress Testing Incidence at 24 Monthsft r Index Coronary R vascularizationTable 3 St ess Testing Incide ce at 24 MonthsAfter Index Coronary Revascularization
All
(n  28,177)
PCI
(n  21,046)
CABG
(n  7,131)
Any stress test 58 61 51
Stress echocardiography 7 7 6
Nuclear stress imaging 50 52 42
Exercise electrocardiography 6 6 8
Repeat stress testing 11 12 9
ata are expressed as percentages of the total revascularization population.
Abbreviations as in Table 1.
Figure 2 Additional Proportion of Patients With
Stress Testing After Revascularization
Graph showing additional proportion of patients undergoing stress testing in
successive 30-day intervals after revascularization. Each value marked on the
horizontal axis represents the lower bound of the 30-day interval (90 refers to
90 to 119 days, 120 refers to 120 to 149 days, etc.). Abbreviations as in
Figure 1.ield of stress testing. Of patients undergoing stress test-
ng within 2 years, 11% had a subsequent coronary angio-
ram within 30 days of testing. Of those patients undergo-
ng stress testing followed by coronary angiography, only
umulative Incidence of Stress Testingt 24 Months After Revascularization inelect Patie t Subgroups
Table 4
Cumulative In idenc of Stress Testing
at 24 Months After Revascularization in
Select Patient Subgroups
Patient Characteristics
Stress Testing
Incidence (%) p Value
Sex
Female 58 0.62
Male 59
Age (yrs)
45 59 0.04
45 to 54 59
55 to 64 58
Diabetes mellitus
Yes 56 0.005
No 59
Congestive heart failure
Yes 52 0.001
No 59
Hyperlipidemia
Yes 61 0.001
No 56
Previous myocardial infarction
Yes 56 0.62
No 59
Tobacco use
Yes 57 0.02
No 59
Renal disease
Yes 53 0.53
No 59
Figure 3 Geographic Variation in
Stress Testing After Revascularization
Graph showing geographic variation in stress testing at 24 months after revas-
cularization in core-based statistical areas with at least 300 revascularization
patients. Dotted horizontal line represents incidence of stress testing after
revascularization for the entire study cohort (59%).
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Cardiac Stress Testing After Revascularization October 12, 2010:1328–346% (48% of PCI and 37% of CABG patients), or 5% of all
atients tested, underwent repeat revascularization.
iscussion
lthough the routine use of stress testing within 2 years of
evascularization is considered inappropriate by recent
CCF AUC (5–7), more than 50% of patients of a large
ational insurance provider had at least 1 stress test between
0 days and 2 years after coronary revascularization in
ommunity practice. Further, we observed a bimodal pat-
ern in stress testing in PCI patients, with the highest
ncidence of testing observed at 6 and 12 months after
evascularization. Of the patients tested, only approxi-
ately 1 in 10 went on to subsequent diagnostic coronary
ngiography, and only 1 in 20 patients underwent repeat
evascularization.
The variation in cardiac imaging and procedures in the
.S. was previously analyzed in Medicare claims data
hrough the Dartmouth Atlas Project (11). These investi-
ators found that geographic variation in use of imaging
rocedures was as high as 10-fold and that the most
ignificant predictor of imaging use was where a patient
ived. Furthermore, they found that there was not an inverse
elationship between invasive and noninvasive testing to
uggest that these tests were interchangeable, and in fact,
ore noninvasive testing led to more invasive investigations.
ther studies have similarly shown up to 4-fold geographic
ariation in the use of echocardiography (12). Similar data
re present for use of coronary angiography, with the
resence of the technical capability to perform a cardiac
atheterization being more predictive than any clinical
actor (13), and significant geographic variation in cardiac
ngiography after acute myocardial infarction (14).
We found in a large national claims database that stress
esting use after coronary revascularization also shows geo-
raphic variations, and that such patterns still persist more
han 10 years after their initial description. We found up to
50% difference in rates of testing between regions. Unlike
rior work in this area, we were able to describe the
emporal trends in stress testing in a non-Medicare popu-
ation. To the best of our knowledge, our study is the first to
emonstrate 2 periods of increased testing incidence at 6
nd 12 months after revascularization that seem to corre-
pond to elective outpatient follow-up visits. Furthermore,
ur finding that for every 2 patients undergoing diagnostic
ngiograms, only 1 revascularization occurs after stress
esting parallels findings previously reported in the Dart-
outh Atlas project, in which national invasive imaging and
evascularization patterns also were examined (15).
Recent single-center investigations have shown that in-
ppropriate stress testing rates approach 20% for both stress
uclear and stress echocardiography tests (16). It is reason-
ble to assume that the frequency and variation in testing
ound in our study is reflective of the uncertainty of evidence
o direct clinical decision-making. Beyond the lack of huidelines, variation in cardiac imaging use may be influ-
nced by physician attitudes and training, patient prefer-
nces, inappropriate use, and other nonclinical factors not
aptured in an administrative dataset. However, our study
traddled the publication of the various ACCF AUC
tatements, limiting our ability to determine the effect of
hese guidelines on cardiac testing patterns.
Undoubtedly, some portion of testing identified in this
nalysis corresponds to clinical follow-up, where cardiac
ymptoms are more likely to be elicited and reported.
urveillance testing and testing in patients with silent
schemia before revascularization likely also account for
ome of the testing. We observed that the rate of testing
eems to be higher for patients undergoing PCI. The higher
ates in patients with PCI may be related to concerns of
estenosis or incomplete revascularization in these patients
s compared with patients undergoing CABG. Unfortu-
ately, we have limited information on symptoms and
linical indications beyond ICD-9 diagnosis codes at the
ime of stress. As a result, our results should be considered
ypothesis generating with regard to appropriateness of
esting. However, if we compare our 40% stress test inci-
ence 1 year after PCI with data from the National Heart,
ung and Blood Institute dynamic registry indicating that
8% of PCI patients report angina symptoms at the 1-year
ollow-up (17), we can surmise that testing occurred more
requently than would be predicted from symptoms alone.
The finding that only 10% of patients with stress testing
ndergo coronary angiography suggests that testing in this
opulation identified a very small proportion of patients that
ither had positive stress test results or other indications for
urther invasive investigation. In patients who proceeded to
iagnostic angiography after testing, less than half under-
ent repeat revascularization. As a result, the overall diag-
ostic yield of stress testing to identify patients requiring
epeat revascularization seems very low even in regions with
igh testing rates. These findings suggest that an opportu-
ity exists to improve the selection of patients that should
ndergo post-revascularization testing. The ACCF AUC
rovide guidance for indications for testing, thereby allow-
ng allocation of testing resources to those patients most
ikely to benefit from further invasive testing and repeat
evascularization (16,18,19).
Cardiologists are under considerable scrutiny for overuse
f imaging and testing (20–23). Variation in clinical prac-
ice matters because uncertainty about the appropriate
pplication of stress testing leads to more testing overall
12). False-positive testing and testing in inappropriate
opulations leads to increased costs and risks for patients,
educes the accuracy of tests (24), and may impact overall
uality of care negatively. Additionally, mounting evidence
uggests that excessive testing results in unnecessary and
ontrivial radiation exposure (25,26). Finally, the lack of
vidence to date that imaging significantly improves clinical
utcomes requires that ordering physicians prudently assess
ow the proposed testing would change care decisions (3).
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October 12, 2010:1328–34 Cardiac Stress Testing After Revascularizationtudy limitations. There are limitations to the current
nalysis that should be considered. First, our observations
re derived from an administrative dataset, limiting the
ranularity of clinical data. We relied on ICD-9 codes to
dentify comorbid conditions at the time of revasculariza-
ion; these codes may represent outcomes of the procedure
s opposed to pre-existing conditions. We do not have
nformation on symptoms after revascularization, stress
esting before patients’ initial coverage date, and whether
tress testing altered medical management in patients.
dditionally, our findings are based on 1 national insurer of
orking-age adults and the geographic markets in which it
perates, perhaps limiting the generalizability of our results
o older patients, other regions, and other reimbursement
nvironments.
We could not identify early testing carried out for
ppropriate indications, such as clearance for cardiac reha-
ilitation or workforce participation. However, we excluded
ll stress tests occurring within 90 days of revascularization,
he period during which such testing is most likely to occur.
s a result, our estimate of stress testing incidence is
onservative.
onclusions
ur findings provide a perspective on the real-world pat-
erns of stress testing after revascularization and, more
mportantly, on the geographic variability and yield of
ost-revascularization stress imaging in community prac-
ice. Half of all patients in community practice had 1 or
ore stress tests within 24 months of coronary revascular-
zation. Of those tested, only 5% required repeat revascu-
arization. Our study suggests that there is significant
pportunity to implement ACCF AUC to ensure the
ppropriate and efficient use of cardiac stress testing. Fur-
her studies are warranted to investigate specific drivers for
tress testing and the possible role of ACCF AUC in
uiding clinical decision-making.
eprints requests and correspondence: Dr. Bimal R. Shah, Duke
linical Research Institute, 2400 Pratt Street, Durham, North
arolina 27705. E-mail: bimal.shah@duke.edu.
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